The advanced-DiaRem score improves prediction of diabetes remission 1 year post-Roux-en-Y gastric bypass

Diabetologia

Volumn 60, Issue 10, 2017, Pages 1892-1902

  Aron Wisnewsky, Judith ^a,b   Sokolovska, Nataliya ^a,b   Liu, Yuejun ^a,b   Comaneshter, Doron S ^c   Vinker, Shlomo ^c,d   Pecht, Tal ^e   Poitou, Christine ^a,b   Oppert, Jean Michel ^a   Bouillot, Jean Luc ^f   Genser, Laurent ^a   Dicker, Dror ^d,g   Zucker, Jean Daniel ^a,b   Rudich, Assaf ^e   Clément, Karine ^a,b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c CLALIT HEALTH SERVICES   (Israel)

^d TEL AVIV UNIVERSITY   (Israel)

^e BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^f HÔPITAL AMBROISE PARÉ   (France)

^g RABIN MEDICAL CENTER   (Israel)

Author keywords

Bariatric surgery; Diabetes remission; Obese; Type 2 diabetes mellitus

Indexed keywords

HEMOGLOBIN A1C; INSULIN; METFORMIN; LIPID;

ABDOMINAL FAT; ADOLESCENT; ADULT; ARTICLE; BODY COMPOSITION; BODY MASS; CLASSIFICATION ALGORITHM; COHORT ANALYSIS; DIABETIC PATIENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAREM SCORE; DISEASE DURATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FALSE POSITIVE RESULT; FAT MASS; FEMALE; FRANCE; HEMOGLOBIN BLOOD LEVEL; HOMEOSTASIS MODEL ASSESSMENT; HUMAN; INSULIN TREATMENT; ISRAEL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; REMISSION; RETROSPECTIVE STUDY; ROUX-EN-Y GASTRIC BYPASS; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; ANALYSIS; BLOOD; GASTRIC BYPASS SURGERY; GLUCOSE BLOOD LEVEL; INSULIN RESISTANCE; MORBID OBESITY; PHYSIOLOGY; PROGNOSIS; TREATMENT OUTCOME;

ADIPOSITY; ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; FRANCE; GASTRIC BYPASS; HUMANS; INSULIN RESISTANCE; LIPIDS; MALE; MIDDLE AGED; OBESITY, MORBID; PROGNOSIS; REMISSION INDUCTION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 85025471170     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-017-4371-7     Document Type: Article

References (44)

1. Buse JB, Caprio S, Cefalu WT et al (2009) How do we define cure of diabetes? Diabetes Care 32:2133–2135
2. Rubino F, Nathan DM, Eckel RH et al (2016) Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations. Diabetes Care 39:861–877
3. Angrisani L, Santonicola A, Iovino P et al (2015) Bariatric surgery worldwide 2013. Obes Surg 25:1822–1832
4. Schauer PR, Mingrone G, Ikramuddin S, Wolfe B (2016) Clinical outcomes of metabolic surgery: efficacy of glycemic control, weight loss, and remission of diabetes. Diabetes Care 39:902–911
5. Pournaras DJ, Aasheim ET, Søvik TT et al (2012) Effect of the definition of type II diabetes remission in the evaluation of bariatric surgery for metabolic disorders. Br J Surg 99:100–103
6. Davies SW, Efird JT, Guidry CA et al (2014) Long-term diabetic response to gastric bypass. J Surg Res 190:498–503
7. Mingrone G, Panunzi S, De Gaetano A et al (2015) Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet 386:964–973
8. Verger EO, Aron-Wisnewsky J, Dao MC et al (2015) Micronutrient and protein deficiencies after gastric bypass and sleeve gastrectomy: a 1-year follow-up. Obes Surg 26:785–796
9. Aron-Wisnewsky J, Verger EO, Bounaix C et al (2016) Nutritional and protein deficiencies in the short term following both gastric bypass and gastric banding. PLoS One 11:e0149588
10. Hayes MT, Hunt LA, Foo J et al (2011) A model for predicting the resolution of type 2 diabetes in severely obese subjects following Roux-en Y gastric bypass surgery. Obes Surg 21:910–916
11. Ramos-Levi AM, Matia P, Cabrerizo L et al (2014) Statistical models to predict type 2 diabetes remission after bariatric surgery. J Diabetes 6:472–477
12. Lee W-J, Hur KY, Lakadawala M et al (2013) Predicting success of metabolic surgery: age, body mass index, C-peptide, and duration score. Surg Obes Relat Dis 9:379–384
13. Still CD, Wood GC, Benotti P et al (2014) Preoperative prediction of type 2 diabetes remission after Roux-en-Y gastric bypass surgery: a retrospective cohort study. Lancet Diabetes Endocrinol 2:38–45
14. Cotillard A, Poitou C, Duchâteau-Nguyen G et al (2015) Type 2 diabetes remission after gastric bypass: what is the best prediction tool for clinicians? Obes Surg 25:1128–1132
15. Lee W-J, Chong K, Chen S-C et al (2016) Preoperative prediction of type 2 diabetes remission after gastric bypass surgery: a comparison of DiaRem scores and ABCD scores. Obes Surg 26:2418–2424
16. Liu Y, Aron-Wisnewsky J, Marcelin G et al (2016) Accumulation and changes in composition of collagens in subcutaneous adipose tissue after bariatric surgery. J Clin Endocrinol Metab 101:293–304
17. Dicker D, Yahalom R, Comaneshter DS, Vinker S (2016) Long-term outcomes of three types of bariatric surgery on obesity and type 2 diabetes control and remission. Obes Surg 26:1814–1820
18. American Diabetes Association (2015) 2. Classification and diagnosis of diabetes. Diabetes Care 38:S8–S16
19. Matthews DR, Hosker JP, Rudenski AS et al (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419
20. Ciangura C, Bouillot J-L, Lloret-Linares C et al (2010) Dynamics of change in total and regional body composition after gastric bypass in obese patients. Obesity (Silver Spring) 18:760–765
21. Arner E, Westermark PO, Spalding KL et al (2010) Adipocyte turnover: relevance to human adipose tissue morphology. Diabetes 59:105–109
22. Divoux A, Tordjman J, Lacasa D et al (2010) Fibrosis in human adipose tissue: composition, distribution, and link with lipid metabolism and fat mass loss. Diabetes 59:2817–2825
23. Bedossa P, Poitou C, Veyrie N et al (2012) Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients. Hepatology 56:1751–1759
24. Bedossa P, Tordjman J, Aron-Wisnewsky J et al (2016) Systematic review of bariatric surgery liver biopsies clarifies the natural history of liver disease in patients with severe obesity. Gut. doi:10.1136/gutjnl-2016-312238
25. Dixon JB, le Roux CW, Rubino F, Zimmet P (2012) Bariatric surgery for type 2 diabetes. Lancet 379:2300–2311
26. Courcoulas AP, Christian NJ, Belle SH, Longitudinal Assessment of Bariatric Surgery (LABS) Consortium et al (2013) Weight change and health outcomes at 3 years after bariatric surgery among individuals with severe obesity. JAMA 310:2416–2425
27. Amutha A, Mohan V (2016) Diabetes complications in childhood and adolescent onset type 2 diabetes-a review. J Diabetes Complications 30:951–957
28. Arterburn DE, Bogart A, Sherwood NE et al (2013) A multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass. Obes Surg 23:93–102
29. Schauer PR, Bhatt DL, Kirwan JP, STAMPEDE Investigators et al (2014) Bariatric surgery versus intensive medical therapy for diabetes—3-year outcomes. N Engl J Med 370:2002–2013
30. Holman RR (1998) Assessing the potential for alpha-glucosidase inhibitors in prediabetic states. Diabetes Res Clin Pract 40(Suppl):S21–S25
31. Montanya E, Fonseca V, Colagiuri S et al (2016) Improvement in glycated haemoglobin evaluated by baseline body mass index: a meta-analysis of the liraglutide phase III clinical trial programme. Diabetes Obes Metab 18:707–710
32. American Diabetes Association (2017) Standards of medical care in diabetes—2017: summary of revisions. Diabetes Care 40(Suppl 1):S4–S5
33. Inzucchi SE, Bergenstal RM, Buse JB et al (2012) Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 35:1364–1379
34. Nazare J-A, Smith J, Borel A-L, INSPIRE ME IAA Investigators et al (2015) Usefulness of measuring both body mass index and waist circumference for the estimation of visceral adiposity and related cardiometabolic risk profile (from the INSPIRE ME IAA study). Am J Cardiol 115:307–315
35. Furet J-P, Kong L-C, Tap J et al (2010) Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes 59:3049–3057
36. Aron-Wisnewsky J, Clement K (2014) The effects of gastrointestinal surgery on gut microbiota: potential contribution to improved insulin sensitivity. Curr Atheroscler Rep 16:454
37. Abdennour M, Reggio S, Le Naour G et al (2014) Association of adipose tissue and liver fibrosis with tissue stiffness in morbid obesity: links with diabetes and BMI loss after gastric bypass. J Clin Endocrinol Metab 99:898–907
38. Chikunguwo SM, Wolfe LG, Dodson P et al (2010) Analysis of factors associated with durable remission of diabetes after roux-en-Y gastric bypass. Surg Obes Relat Dis 6:254–259
39. Aminian A, Brethauer SA, Kashyap SR et al (2014) DiaRem score: external validation. Lancet Diabetes Endocrinol 2:12–13
40. Eliaschewitz FG, Tambascia MA (2012) Can we prevent beta cell apoptosis in type 2 diabetes? Diabetes Metab Res Rev. doi:10.1002/dmrr.2381
41. UK Prospective Diabetes Study Group (1995) UK prospective diabetes study 16. Overview of 6 years’ therapy of type II diabetes: a progressive disease. Diabetes 44:1249–1258
42. Schauer PR, Bhatt DL, Kirwan JP, STAMPEDE Investigators et al (2017) Bariatric surgery versus intensive medical therapy for diabetes—5-year outcomes. N Engl J Med 376:641–651
43. Fried M, Yumuk V, Oppert JM, International Federation for Surgery of Obesity and Metabolic Disorders-European Chapter (IFSO-EC), European Association for the Study of Obesity (EASO), European Association for the Study of Obesity Obesity Management Task Force (EASO OMTF) et al (2014) Interdisciplinary European guidelines on metabolic and bariatric surgery. Obes Surg 24:42–55
44. Mechanick JI, Youdim A, Jones DB et al (2013) Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient – 2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & bariatric surgery. Obesity (Silver Spring) 21(Suppl 1):S1–27